Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM IVFH
FY Dec 2025
n/a
FY Dec 2024
$72.1M
FY Dec 2023
$72.2M
FY Dec 2022
$80.1M
FY Dec 2021
$62.2M
Jun 2026
$13.1M
Mar 2026
$12.2M
Dec 2025
$11.4M
Sep 2025
$16.4M
Jun 2025
$21.1M
Mar 2025
$19.5M
Dec 2024
$22.7M
Sep 2024
$17.0M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM IVFH
FY Dec 2025
n/a
FY Dec 2024
+3.6%
FY Dec 2023
-6.1%
FY Dec 2022
-1.7%
FY Dec 2021
-1.2%
Jun 2026
+2.8%
Mar 2026
+15.1%
Dec 2025
+0.8%
Sep 2025
-10.5%
Jun 2025
+0.3%
Mar 2025
-2.2%
Dec 2024
-0.3%
Sep 2024
+7.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$685.5K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM IVFH
FY Dec 2025
-$269.7K
FY Dec 2024
-$6.6M
FY Dec 2023
-$558.0K
FY Dec 2022
-$714.1K
FY Dec 2021
-$3.7M
Jun 2026
$609.0K
Mar 2026
-$264.9K
Dec 2025
$647.2K
Sep 2025
-$305.7K
Jun 2025
$529.6K
Mar 2025
-$1.1M
Dec 2024
-$3.6M
Sep 2024
$472.5K
At each fiscal year end
Single quarter
Debt to equity
0.03x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity IVFH
FY Dec 2025
0.05x
FY Dec 2024
0.04x
FY Dec 2023
3.20x
FY Dec 2022
1.17x
FY Dec 2021
0.79x
Jun 2026
0.03x
Mar 2026
0.03x
Dec 2025
0.05x
Sep 2025
0.05x
Jun 2025
1.10x
Mar 2025
1.13x
Dec 2024
0.04x
Sep 2024
1.49x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
3.00x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt IVFH
FY Dec 2025
-0.10x
FY Dec 2024
-17.18x
FY Dec 2023
-0.05x
FY Dec 2022
-0.08x
FY Dec 2021
-0.62x
Jun 2026
3.00x
Mar 2026
2.69x
Dec 2025
-0.10x
Sep 2025
-14.20x
Jun 2025
-0.36x
Mar 2025
-0.46x
Dec 2024
-17.18x
Sep 2024
-0.11x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity IVFH
FY Dec 2025
-27.8%
FY Dec 2024
+47.4%
FY Dec 2023
-93.7%
FY Dec 2022
-19.3%
FY Dec 2021
-12.7%
Jun 2026
+7.0%
Mar 2026
+3.4%
Dec 2025
-27.8%
Sep 2025
-35.2%
Jun 2025
+14.7%
Mar 2025
+12.2%
Dec 2024
+47.4%
Sep 2024
+18.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets IVFH
FY Dec 2025
-8.5%
FY Dec 2024
+10.7%
FY Dec 2023
-19.7%
FY Dec 2022
-5.7%
FY Dec 2021
-3.1%
Jun 2026
+3.2%
Mar 2026
+1.5%
Dec 2025
-8.5%
Sep 2025
-10.2%
Jun 2025
+4.1%
Mar 2025
+3.4%
Dec 2024
+10.7%
Sep 2024
+4.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+32.1%
operating income after a 4.8% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital IVFH
FY Dec 2025
+40.0%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+32.1%
Mar 2026
+37.4%
Dec 2025
+40.0%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
-0.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+17.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed IVFH
FY Dec 2025
+21.0%
FY Dec 2024
n/a
FY Dec 2023
-28.5%
FY Dec 2022
-7.8%
FY Dec 2021
-29.3%
Jun 2026
+17.5%
Mar 2026
+20.8%
Dec 2025
+21.0%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
-0.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
4.23x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing IVFH
FY Dec 2025
9.33x
FY Dec 2024
31.23x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
7.69x
Mar 2026
7.35x
Dec 2025
9.33x
Sep 2025
16.22x
Jun 2025
26.00x
Mar 2025
52.18x
Dec 2024
31.23x
Sep 2024
88.57x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$7.4M
market value at close 2026-10-26 on 2026-08-12 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value IVFH
FY Dec 2025
$22.9M
FY Dec 2024
$90.1M
FY Dec 2023
$39.9M
FY Dec 2022
$13.0M
FY Dec 2021
$14.6M
Jun 2026
$14.8M
Mar 2026
$17.9M
Dec 2025
$22.9M
Sep 2025
$39.6M
Jun 2025
$78.5M
Mar 2025
$103.5M
Dec 2024
$90.1M
Sep 2024
$65.4M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.6%
TTM free cash flow over market value at close 2026-10-26
FCF yield IVFH
FY Dec 2025
-1.1%
FY Dec 2024
-7.2%
FY Dec 2023
-1.5%
FY Dec 2022
-7.1%
FY Dec 2021
-24.8%
Jun 2026
+4.2%
Mar 2026
+3.2%
Dec 2025
-1.1%
Sep 2025
-11.2%
Jun 2025
-5.2%
Mar 2025
-4.8%
Dec 2024
-7.2%
Sep 2024
-2.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -22%, PEG needs growth
PEG, trailing IVFH
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
0.19x
Dec 2025
n/a
Sep 2025
0.07x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
IVFH ranks highest on financial health (87th percentile) and risk and compliance (70th), and lowest on growth (43rd), among Wholesale & Retail peers.
Profitability
64
Inputs
Return on equity+7.0% · 48 pct, sector of 206
Return on assets+3.2% · 55 pct, sector of 257
Return on invested capital+32.1% · 78 pct, sector of 109
Return on capital employed+17.5% · 76 pct, sector of 220
Financial health
87
Inputs
Debt to equity0.03x · 81 pct, sector of 222
Cash flow to debt3.00x · 92 pct, sector of 210
Growth
43
Inputs
Revenue growth, YoY+2.1% · 43 pct, sector of 311
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
70
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 317
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 242
New text in Risk Factors, latest 10-K+27.7% · 11 pct, sector of 226
3 not measured: Insider conviction, Institutional and government, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.